Opinion Article: Cardiac Diagnostics in Practice Puts Patients' Best Interests at Heart

By Joshua Rowe, CEO of Broomwell Healthwatch.
Imagine that you start to experience unfamiliar chest pains. What would you do? Like most people, you're likely to call or visit your GP surgery and ask for an emergency appointment. The problem is, a majority of surgeries are not equipped to perform any meaningful cardiac diagnostic tests, such as an ECG: instead, you're likely to be referred to a hospital for tests in several days' time.

Now think about the impact this has. You remain anxious and concerned while waiting for your appointment. You may have to travel miles to the hospital or clinic for the test, taking more time off work to do so, perhaps at considerable inconvenience via public transport. You continue to be stressed while waiting for the test results.

This is obviously far from ideal. But anxiety, waiting and inconvenience is the reality for most people with symptoms of chest pain. The complexity of this diagnostic pathway for patients also makes it a costly reality for the NHS.

But why do so many patients have to start on this pathway from primary to secondary care at all, just for simple tests? After all, while symptoms of chest pain could indicate heart problems, they are also just as likely to have other, non life-threatening causes.

Wouldn't it make more sense to be able to assess the patient's cardiac health in a primary care setting, before involving secondary care providers or emergency services? This could mean enormous cost and resource savings for the NHS, easing the burden on already stretched resources; not to mention the benefits to patients.

Immediacy of diagnosis reduces anxiety and tension for patients (and at the same time, makes savings in the economy as a whole: so many working days are otherwise lost to unnecessary health appointments). What's more, identifying and addressing problems at an earlier stage - without several days' wait for a test and its results - means patients receive more timely and preventative support, ensuring optimal care.

Calling up expert help
The most common method of diagnosing cardiac conditions is the ECG. However, as mentioned earlier, most GP surgeries don't have access to ECG machines, or the in-house skills and experience required for accurate interpretation of ECG traces.

This is where a telemedical ECG approach has proven tremendously successful, with take-up by Trusts and practices growing rapidly. A cardiac telemedical service enables a GP or practice nurse to record a full 12-lead ECG using a handheld unit, and then transmit the ECG trace via telephone to a 24-hour monitoring centre staffed by expert cardiac clinicians. When the trace is interpreted (within 2 to 3 minutes), the clinician give the GP or nurse an immediate verbal evaluation, followed by a written report.

In effect, this approach imports the same kind of cardiac expertise found in hospitals into a GP surgery, enabling a full on-the-spot ECG test and assessment for patients and cutting out waiting times for outpatient appointments or hospital diagnostic tests.

Evidence matters
A long-term project, started in 2007 by the Greater Manchester & Cheshire Cardiac and Stroke Network (GMCCSN) has proven the benefits of the telemedical ECG equipment and service both to patients and to the NHS. It has drastically reduced unnecessary outpatient appointments, freeing up secondary healthcare resources, and quickly generating significant, ongoing savings. The service is used by over 150 GP practices in nine PCTs across the GMCCSN, as well as in many in other parts of the country.

The latest results from practices using the service showed that over 90% of patients did not need any referrals to hospital. Even when the telemedical ECG service was used on symptomatic patients, 90% of these did not require a referral, and could be treated in a primary care setting.

It's here that the savings possible with the telemedical service are realised: a single average hospital outpatient appointment costs £155, and a single hospital-based diagnostic test (ECG) is £46 - not including the cost to patients in terms of anxiety, time and travel. The costs of the telemedical ECG service are a fraction of this.

So the benefits are evident. Cardiac telemedicine in GP surgeries realises very significant ongoing cost savings by reducing secondary care referrals and reliance on hospital-based testing. This not only cuts waiting lists, but also gives patients easier, faster access to diagnoses for worrying symptoms of chest-pain, reducing anxiety and inconvenience.

The work done by the GMCCSN also shows how easily this service can be brought into the mainstream of cardiac care pathways across a large population. This helps Trusts ease the burden that cardiac care places on their A&E and outpatients departments - all the while keeping the patients' best interests at heart.

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...